Company: QTIWW
Filing Date: 2025-12-29
Form Type: S-1/A
Source: 0001628280-25-058960
Chunk: 257

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-12-29
Form: S-1/A
Chunk 257
---
as Budagov(3) (4)                                               
 Former Chief Financial Officer                                       |     |      |     | 2023 |     |   |         |     |        |       — |     |   |         |     |                      | — |     |   |        |     |       | — |     |   |     |              |      — |     |   |         |     |       |       — |
|                                                                      |     | 2024 |     |      |     | $ | 290,846 |     |        |         |     | $ | 153,725 |     |                      |   |     | $ | 63,333 |     |       |   |     | — |     |              |        |     | $ | 507,904 |     |       |         |
| Mikel Ann Price(5)                                                   
 Former Chief Financial Officer                                       |     |      |     | 2023 |     |   |         |     | $      | 267,596 |     |   |         |     |                      | — |     |   |        |     |       | — |     |   |     | $            | 22,211 |     |   |         |     | $     | 289,907 |
|                                                                      |     | 2024 |     |      |     |   |       — |     |        |         |     |   |       — |     |                      |   |     |   |      — |     |       |   |     | — |     |              |        |     |   |       — |     |       |         |

__________________

(1) Consists of shares of Common Stock of the Company issuable upon vesting and exercise of stock options. The amounts in this column represent the aggregate grant date fair value computed in accordance with FASB ASC Topic 718.

(2) On March 12, 2024, the Board appointed Dr. Raluca Dinu to serve as the Chief Executive Officer of the Company, effective immediately. Dr. Raluca Dinu’s ba se salary per her employment agreement, which the Board approved on March 18, 2024, effective as of March 12, 2024 was $470,000. On July 3, 2024, the Board approved the grant of 183,333 stock options to Dr. Raluca Dinu. The stock options have an exercise price of